Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Worldwide Offices
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Verified Clinical Trials and Chubb Announce Strategic Alliance to Advance Research Subject Safety, Data Quality, and Clinical Trial Success

This image opens in the lightbox

News provided by

Verified Clinical Trials LLC

28 Apr, 2026, 14:27 GMT

Share this article

Share toX

Share this article

Share toX

BOCA RATON, Fla., April 28, 2026 /PRNewswire/ -- Verified Clinical Trials (VCT), the global leader in clinical trial subject registry solutions, and Chubb today announced a strategic alliance focused on enhancing research subject safety, improving data quality, strengthening study integrity, and supporting successful clinical trial outcomes.

Continue Reading
This image opens in the lightbox
Verified Clinical Trials and Chubb Announce Strategic Alliance to Advance Research Subject Safety, Data Quality, and Clinical Trial Success

Chubb's partnering with Verified Clinical Trials, who offers proprietary subject registry technology, is part of a broader clinical trial risk management approach. VCT's clinical trial subject registry solutions are designed to detect and help prevent duplicate enrollment and other important protocol violations at the time of screening - issues that can compromise research subject safety, affect data quality, create operational and regulatory challenges, and increase the risk of study failure.

Key Benefits of the Alliance Include:

  • Enhanced Research Subject Safety: Helping reduce the risk of duplicate or overlapping study participation that may contribute to adverse events, drug interactions, and other safety concerns.
  • Improved Data Quality: Supporting cleaner, more reliable study data for stronger analysis, decision-making, and regulatory submissions.
  • Greater Study Integrity: Helping reinforce protocol compliance and protect against violations that can undermine trial validity.
  • Reduced Risk Exposure: Helping sponsors, CROs, and sites mitigate preventable operational, financial, regulatory, and potential liability risks.
  • Stronger Potential for Clinical Trial Success: Supporting better-protected studies with a higher likelihood of meeting research objectives.
  • Broader Public Benefit: Helping support the development of safer, more effective drugs and therapies for the patients and communities who rely on them.

Chubb is the leading global underwriter of clinical trials and a longstanding market leader that tailors insurance solutions for life sciences companies, with the scale, expertise, and international capabilities to support pharmaceutical and biotechnology companies ranging from emerging innovators to some of the largest in the world. Chubb clients can benefit from an additional layer of protection against adverse events (AEs), serious adverse events (SAEs), protocol deviations, and compromised data quality associated with duplicate or undisclosed study participation.

By combining Chubb's clinical trial insurance capabilities with VCT's industry-recognized subject registry technology, this alliance is positioned to provide meaningful, additive benefits to sponsors, CROs, research sites, and ultimately research subjects. Together, these complementary services can help reduce preventable risk, improve research subject safety, strengthen protocol compliance, enhance data quality and study integrity, and support more successful clinical trial execution.

"Research subject safety and data integrity are fundamental to every successful clinical trial," said Dr. Mitchell Efros, Co-Founder & CEO at Verified Clinical Trials. "This alliance with Chubb represents an important opportunity to help bring greater protection, stronger oversight, and added value to the clinical research ecosystem. Ultimately, the broader public stands to benefit as well, as safer, more effective drugs and therapies can be developed and brought forward with greater confidence for patient use."

"Chubb is committed to supporting innovative and practical approaches to risk management in clinical research," said Lee Farrow, EVP, Life Sciences Industry Practice Leader at Chubb. "VCT addresses a longstanding and underrecognized challenge in clinical research: the inability to reliably look into a participant's research history to confirm eligibility. This alliance with VCT reflects a shared focus on improving research subject safety, study integrity, and overall trial performance."

"At Verified Clinical Trials, our mission has always been to strengthen the integrity of clinical research while prioritizing the safety of research participants," said Kerri Weingard, Co-Founder, VP and Global COO of Verified Clinical Trials. "This alliance with Chubb represents a meaningful advancement in how the industry approaches risk - moving from reactive to proactive safeguards. By combining VCT's real-time subject verification capabilities with Chubb's global risk management expertise, we are helping to create a more secure, transparent, and reliable clinical trial ecosystem that ultimately benefits sponsors, sites, and, most importantly, patients."

This alliance represents an important step forward in advancing proactive risk management in clinical trials and underscores the value of collaboration between insurers and clinical trial technology leaders working to improve clinical research outcomes worldwide.

About Verified Clinical Trials
Verified Clinical Trials (VCT) is a leading provider of clinical trial subject registry solutions designed to detect and help prevent duplicate enrollment and other protocol violations. Its secure global database is trusted by research sites, sponsors, and CROs to help improve research subject safety, strengthen protocol compliance, and protect data integrity.

About Chubb
Chubb is a world leader in insurance. With operations in 54 countries and territories, Chubb provides commercial and personal property and casualty insurance, personal accident and supplemental health insurance, reinsurance and life insurance to a diverse group of clients. The company is defined by its extensive product and service offerings, broad distribution capabilities, exceptional financial strength and local operations globally. Parent company Chubb Limited is listed on the New York Stock Exchange (NYSE: CB) and is a component of the S&P 500 index. Chubb employs approximately 45,000 people worldwide. Additional information can be found at: https://www.chubb.com/.

Media Contact:
Justin Goodarz
Chief Commercial Officer
Verified Clinical Trials, LLC
Connect@verifiedclinicaltrials.com
(516) 998-7499

Disclaimer: The non-insurance products and services described herein are provided by Verified Clinical Trials, a third party vendor not affiliated with Chubb. The fact that offers and potential discounts may be made available by this vendor is not an indication that insurance coverage is available under any Chubb policy for any particular incident. Referenced discounts on products and services offered by Verified Clinical Trials are available only to Chubb policyholders with current in-force policies and are subject to applicable insurance laws. For products and services provided, the policyholder and third party vendor would enter into a vendor relationship directly. Chubb will not be involved in the policyholder's decision to purchase services and has no responsibility for services that may be provided. 

Logo - https://mma.prnewswire.com/media/2967165/Verified_Clinical_Trials_VCT_and_Chubb_Announce_a_Strategic_Alliance_to_Advance_Research_Subject_Saf_Logo.jpg

Logo - https://mma.prnewswire.com/media/2967166/CHUBB_Black_RBG_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • PR Newswire Amplify™
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.